Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Earlier Elderly People in Urban Areas

15 de marzo de 2022 actualizado por: Rosa Sola, University Rovira i Virgili

Characterization, Creativity, Leadership, and Search for Solutions to Improve the Lifestyles of Earlier Elderly People in Urban Areas

Social innovation in aging needs to bring new ideas and services to meet new social and welfare needs identified in recent years. In our environment, people ≥60 years old accounted for 20% -24% of the population in 2015, and it is expected to increase to ≥30% by 2050.

The objectives of this project are: To characterize the elderly (60 to 74 years) who live independently in urban areas of the province of Tarragona, to actively involve them, through a process of participatory research to generate solutions.

To achieve this goal, it is proposed to make a diagnosis of their health status (lifestyles, risk of malnutrition, and sarcopenia), and conduct focus groups including young seniors from urban areas, and stakeholders, to determine their needs, interests, and barriers for pursuing healthy lifestyles. Based on the information obtained in the diagnosis and focus groups, there will be processes for co-creating solutions based on proposed activities or changes in their immediate environment.

Descripción general del estudio

Descripción detallada

Social innovation in aging needs to bring new ideas and services to meet new social and welfare needs identified in recent years. In our environment, people ≥60 years old accounted for 20% -24% of the population in 2015, and it is expected to increase to ≥30% by 2050. For the first time in history, most people can aspire to live well beyond the age of 60. On the other hand, the Covid-19 pandemic has severely affected people ≥60 years of age and may make the welfare and health problems of this population more evident, such as unhealthy lifestyles, the risk of malnutrition, and sarcopenia (defined as loss of muscle mass, strength, and function), which leads to significant dependency and quality of life problems. In addition, older people living in urban areas have been severely affected by confinement, and new needs are being generated. To better understand the needs, an innovative element of this project is to involve the elderly-young people (60-74 years) from urban areas in the generation of solutions, which will make these solutions especially adapted to their needs. Therefore increase the adherence to the solutions created, and also the long-term sustainability of the solutions.

The objectives of this project are: To characterize the elderly (60 to 74 years) who live independently in urban areas of the province of Tarragona, to actively involve them, through a process of participatory research to generate solutions.

To achieve this goal, it is proposed to make a diagnosis of their health status (lifestyles, risk of malnutrition, and sarcopenia), and conduct focus groups including young seniors from urban areas, and stakeholders, to determine their needs, interests, and barriers for pursuing healthy lifestyles. Based on the information obtained in the diagnosis and focus groups, there will be processes for co-creating solutions based on proposed activities or changes in their immediate environment. During the co-creation process, the elderly and the 4-helix stakeholders (government, industry, university, and civil society) will be involved.

Tipo de estudio

De observación

Inscripción (Anticipado)

77

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Tarragona
      • Reus, Tarragona, España
        • University Rovira i Virgili
      • Reus, Tarragona, España, 43204
        • Institut d'Investigació Sanitaria Pere i Virgili

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

60 años a 74 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

N/A

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra de probabilidad

Población de estudio

Earlier elderly people living in urban areas. The target population will be recruited from different places in the community, town halls, civic centers, senior citizens' associations, etc.

Descripción

Inclusion Criteria:

  • People ≥60 years and ≤75 years,
  • That they have informed consent,
  • Living at home (living independently), Community-dwelling early-elderly
  • That they can continue the study,
  • They live in the province of Tarragona

Exclusion Criteria:

  • Failure to comply with the inclusion criteria will be considered an exclusion criterion.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Risk of sarcopenia (muscle strength)
Periodo de tiempo: 1 day
Reduction of muscle strength: <27kg in men and <16kg in women measured by a dynamometer
1 day
Diagnosis of sarcopenia (muscle strength)
Periodo de tiempo: 1 day
Reduction of muscle strength (<27kg in men and <16kg in women measured by a dynamometer)
1 day
Diagnosis of sarcopenia (muscle mass)
Periodo de tiempo: 1 day
Reduction of muscle mass (<20kg in men and <15kg in women measured by bioimpedance)
1 day
Diagnosis of severe sarcopenia (muscle strength)
Periodo de tiempo: 1 day
Reduction of muscle strength (<27kg in men and <16kg in women measured by a dynamometer) and
1 day
Diagnosis of severe sarcopenia (muscle mass)
Periodo de tiempo: 1 day
Reduction of muscle mass (<20kg in men and <15kg in women measured by bioimpedance)
1 day
Diagnosis of severe sarcopenia (muscle function)
Periodo de tiempo: 1 day
Reduction of muscle function (≤0.8 m / s)
1 day

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Nutrition
Periodo de tiempo: 1 day

Food frequency questionnaire

(not scale)

1 day
Physical activity
Periodo de tiempo: 1 day

International physical activity questionnaire for elderly Low category: non-physical activity or it is not enough to achieve moderate or high category Moderate category: 3 or more days / weeks (vigorous physical activity, at least 25 minutes/day), or 5 or more (moderate physical activity, at least 30 minutes/day), or 5 or more days / weeks of a combination of walking, or moderate-vigorous physical activity (at least 600 METS).

High category: 7 or more days / week of a combination of walking, or moderate-vigorous physical activity (at least 3000 METS).

1 day
Sleep behaviour
Periodo de tiempo: 1 day

Pittsburg questionnaire

Pittsburg questionnaire The questionnaire contains a total of 19 questions, grouped into 10 questions. The 19 questions are combined to form seven areas with their corresponding score, each of which shows a range between 0 and 3 points. In all cases, a score of "0" indicates ease, while a score of 3 indicates severe difficulty, within their respective area. The score of the seven areas is finally added to give an overall score, which ranges from 0 to 21 points. "0" indicates ease of sleeping and "21" severe difficulty in all areas.

1 day
Risk of malnutrition
Periodo de tiempo: 1 day
Mini Nutritional Assessment 12-14 points: normal nutritional status 8-11 points: risk of malnutrition 0-7 points: malnutrition
1 day
Weight
Periodo de tiempo: 1 day
Weight using a balance (kg)
1 day
height
Periodo de tiempo: 1 day
Height using a tallimeter (m)
1 day
BMI
Periodo de tiempo: 1 day
Using weight (kg) / height (m)2
1 day

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Age
Periodo de tiempo: 1 day
Age in years
1 day
Gender
Periodo de tiempo: 1 day
Female or male
1 day

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Rosa Sola, Dr, University Rovira i Virgili

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de febrero de 2022

Finalización primaria (Anticipado)

31 de marzo de 2022

Finalización del estudio (Anticipado)

31 de marzo de 2022

Fechas de registro del estudio

Enviado por primera vez

11 de febrero de 2022

Primero enviado que cumplió con los criterios de control de calidad

24 de febrero de 2022

Publicado por primera vez (Actual)

7 de marzo de 2022

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

31 de marzo de 2022

Última actualización enviada que cumplió con los criterios de control de calidad

15 de marzo de 2022

Última verificación

1 de marzo de 2022

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • Earlier-Elderly Urban People

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir